KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Steris (STE) EPS (Weighted Average and Diluted) (2018 - 2026)

Steris' quarterly EPS (Weighted Average and Diluted) came in at $1.96 in Q4 2025, up 12.0% year-on-year from $1.75 in Q4 2024, and up 1.03% quarter-over-quarter from $1.94 in Q3 2025.

Steris has reported EPS (Weighted Average and Diluted) for 8 years, with the latest figure at $1.96 in Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 12.0% year-over-year to $1.96; the trailing twelve-month figure through Dec 2025 stood at $7.12 (up 52.79% YoY), and the FY2025 full-year result was $6.16, up 61.68% from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 stood at $1.96, up from $1.94 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $1.96 in Q4 2025, with the low at -$0.24 in Q2 2021.
  • Average EPS (Weighted Average and Diluted) over 5 years is $1.23, with a median of $1.36 recorded in 2023.
  • Year-over-year, EPS (Weighted Average and Diluted) slumped 122.86% in 2021 and surged 14400.0% in 2025.
  • Tracing STE's EPS (Weighted Average and Diluted) over 5 years: stood at $1.42 in 2021, then slipped by 12.68% to $1.24 in 2022, then climbed by 14.52% to $1.42 in 2023, then increased by 23.24% to $1.75 in 2024, then rose by 12.0% to $1.96 in 2025.
  • The last three EPS (Weighted Average and Diluted) figures came in at $1.96 (Q4 2025), $1.94 (Q3 2025), and $1.79 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.61
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.51
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.24
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 1.22

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.24
Dec 31, 2025 1.96
Sep 30, 2025 1.94
Jun 30, 2025 1.79
Mar 31, 2025 1.43
Dec 31, 2024 1.75
Sep 30, 2024 1.51
Jun 30, 2024 1.41
Mar 31, 2024 -0.01
Dec 31, 2023 1.42
Sep 30, 2023 1.20
Jun 30, 2023 1.31
Mar 31, 2023 1.83
Dec 31, 2022 1.24
Sep 30, 2022 1.24
Jun 30, 2022 1.19
Mar 31, 2022 0.52
Dec 31, 2021 1.42
Sep 30, 2021 0.69
Jun 30, 2021 -0.24
Mar 31, 2021 1.02
Dec 31, 2020 1.33
Sep 30, 2020 1.23
Jun 30, 2020 1.05
Mar 31, 2020 1.43
Dec 31, 2019 1.23
Sep 30, 2019 1.11
Jun 30, 2019 1.00
Mar 31, 2019 1.27
Dec 31, 2018 0.56
Sep 30, 2018 0.91
Jun 30, 2018 0.82
Mar 31, 2018 0.86